The Rise of Targeted Therapies in the Lichen Planus Market

Fri, 07 Feb 2025 11:56:10 +0000

The lichen planus market involves the pharmaceutical treatment of a chronic inflammatory disease that affects the skin and mucous membranes. The disease is considered an autoimmune disorder that results in itchy small raised bumps or blisters on the skin or inside the mouth. The treatment options involve topical corticosteroids that help reduce inflammation and discomfort. The underlying pathophysiology involves the activation of T-cells against constituent self-antigens. The Global Lichen Planus Market is estimated to be valued at USD 150.1 million in 2024 and is expected to reach USD 251.2 million by 2031, growing at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2031.